Eliem Therapeutics所有资讯

Eliem Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(47.5%),Peter Kolchinsky(47.5%)等

04/13 06:53

Eliem Therapeutics | 4：持股变动声明-高管 Morisset Valerie

04/09 05:38

Eliem Therapeutics | 4：持股变动声明-高管 Pimblett Emily

03/21 04:38

Eliem Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(47.5%),Peter Kolchinsky(47.5%)等

03/19 04:51

Eliem Therapeutics | 4：持股变动声明-高管 Morisset Valerie

03/05 00:10

Eliem Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Braden M Leonard(8.5%),BML Investment Partners, L.P.(7.9%)

02/08 00:56

Eliem Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(47.7%),Peter Kolchinsky(47.7%)等

2023/11/18 05:30

Eliem Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)

2023/11/14 06:13

Eliem Therapeutics | 4：持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.

2023/05/23 05:22

Eliem Therapeutics | 4：持股变动声明-董事 Tate Simon

2023/05/23 05:13

Eliem Therapeutics | 4：持股变动声明-董事 Ratcliffe Liam

2023/05/23 05:11

Eliem Therapeutics | 4：持股变动声明-董事 Dunn Judith

2023/05/23 05:08

Eliem Therapeutics | 4：持股变动声明-董事 Rosenberg Adam Joseph

2023/05/23 05:05

Eliem Therapeutics | 4：持股变动声明-董事会执行主席 Levin Andrew David

2023/05/23 05:02

Eliem Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(48.8%),Peter Kolchinsky(48.8%)等

2023/04/11 05:01

Eliem Therapeutics | 3：首次持股声明-首席会计师 Pimblett Emily

2023/03/21 22:21

Eliem Therapeutics | 4：持股变动声明-高管 Morisset Valerie

2023/03/15 05:04

Eliem Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Intermediate Capital Investments Limited(7.5%),Intermediate Capital Group plc(7.5%)

2023/03/09 05:00

Eliem Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Samlyn Capital, LLC(0%),Samlyn, LP(0%)等

2023/02/15 03:22

Eliem Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Braden M Leonard(7.1%),BML Investment Partners, L.P.(6.9%)

2023/02/09 05:35